- Home
- AUTL vs EU Comparison
AUTL vs EU Comparison
Compare AUTL & EU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- EU
- Stock Information
- Founded
- AUTL 2014
- EU 2009
- Country
- AUTL United Kingdom
- EU United States
- Employees
- AUTL N/A
- EU N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- EU Other Metals and Minerals
- Sector
- AUTL Health Care
- EU Basic Materials
- Exchange
- AUTL Nasdaq
- EU Nasdaq
- Market Cap
- AUTL 625.4M
- EU 445.3M
- IPO Year
- AUTL 2018
- EU N/A
- Fundamental
- Price
- AUTL $1.36
- EU $2.61
- Analyst Decision
- AUTL Strong Buy
- EU Strong Buy
- Analyst Count
- AUTL 5
- EU 1
- Target Price
- AUTL $9.12
- EU $4.00
- AVG Volume (30 Days)
- AUTL 4.5M
- EU 4.2M
- Earning Date
- AUTL 11-11-2025
- EU 11-13-2025
- Dividend Yield
- AUTL N/A
- EU N/A
- EPS Growth
- AUTL N/A
- EU N/A
- EPS
- AUTL N/A
- EU N/A
- Revenue
- AUTL $29,934,000.00
- EU $44,524,000.00
- Revenue This Year
- AUTL $641.63
- EU $33.35
- Revenue Next Year
- AUTL $109.21
- EU $112.45
- P/E Ratio
- AUTL N/A
- EU N/A
- Revenue Growth
- AUTL 185.17
- EU N/A
- 52 Week Low
- AUTL $1.11
- EU $1.01
- 52 Week High
- AUTL $5.00
- EU $4.44
- Technical
- Relative Strength Index (RSI)
- AUTL 33.35
- EU 57.30
- Support Level
- AUTL $1.26
- EU $2.21
- Resistance Level
- AUTL $1.46
- EU $2.37
- Average True Range (ATR)
- AUTL 0.09
- EU 0.14
- MACD
- AUTL 0.01
- EU 0.04
- Stochastic Oscillator
- AUTL 30.49
- EU 90.93
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About EU enCore Energy Corp.
enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties of uranium resource properties in the United States. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's Projects are South Texas Operations, Dewey-Burdock Project, Gas Hills Project, Crownpoint & Hosta Butte Project, PFN (Prompt Fission Neutron) Technology, and Other Assets.